Table 4 Results of the multivariable logistic regression models for a binary outcome of experiencing smell and taste impairments during any time of the follow up (months 3 to 18). For these models the acute-phase symptoms were not used.

From: Chemosensory assessment and impact on quality of life in neurosensorial cluster of the post COVID 19 syndrome

Name

Smell impairment at follow-up

AUROC: 0.84

N = 1066, 134 positive

Taste impairment at follow-up

AUROC: 0.83

N = 1077, 127 positive

OR

CI_low

CI_high

p-value

OR

CI_low

CI_high

p-value

Age

0.08

0.03

0.25

 < 0.001

0.04

0.01

0.11

 < 0.001

3rd wave

0.35

0.19

0.64

 < 0.001

    

Hospitalization

0.4

0.12

1.26

0.118

0.45

0.22

0.92

0.029

Monoclonal antibodies

0.45

0.23

0.9

0.025

0.45

0.22

0.89

0.022

Corticosteroids

0.89

0.48

1.63

0.696

1.33

0.72

2.46

0.358

Oxygen therapy

1.11

0.31

3.96

0.872

    

Cardiovascular disease

1.17

0.64

2.14

0.607

    

2nd wave

1.42

0.74

2.73

0.296

2.19

1.23

3.92

0.008

Female

2.31

1.4

3.81

 < 0.001

1.63

1.02

2.63

0.043

  1. AUROC: area under the roc curve; OR: odd ratio; CI: confidence interval.
  2. Significant values are in bold.
Back to article page